ATTITUDES TOWARDS GENERIC SUBSTITUTION IN GREECE

Author(s)

Kyriopoulos D1, Kyriopoulos I2, Athanasakis K1
1National School of Public Health, Athens, Greece, 2London School of Economics and Political Science, London, UK

OBJECTIVES:

Generic substitution is a popular measure for cost containment in pharmaceutical markets. During the last period, it was among the main priorities of the pharmaceutical policy agenda in Greece, and a key element of the economic adjustment programme in health sector. In this context, this study aims to examine the determinants of patients’ attitudes towards generic substitution in Greece.

METHODS:

A cross-sectional survey was conducted on a representative national sample of 2012 adult individuals. The dependent variable is a binary variable regarding the extent to which respondents could accept generic substitution. The independent variables are: urbanity, social status, gender, age, marital status, education, source of information about pharmaceutical care, chronic conditions and knowledge about generics. The empirical analysis was conducted using a logistic regression model.

RESULTS:

Our findings suggest that 39.2% of the respondents were willing to accept generic substitution in the pharmacy, as they considered generic medication as an equal therapeutic alternative to branded pharmaceuticals. Male, high educated and those living in urban areas are more likely to have a positive attitude towards generic substitution. Moreover, respondents who received information from their pharmacists are more likely to accept generic substitution, relative to those being informed by doctors. Chronic patients are less likely to accept generic substitution. In particular, the odds ratios are 0.79 and 0.70 for those having one and two or more conditions respectively. Social status, age, and marital status were not statistically significant determinants of the attitudes towards generic substitution.

CONCLUSIONS:

A significant share of the respondents is reluctant to accept generic substitution. In this context, some specific population groups may need further information about generic drugs and substitution, and the therapeutic equivalence between generics and branded drugs. The findings of this study are useful towards designing targeted interventions for specific population groups in Greece.

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PHP24

Topic

Health Policy & Regulatory

Topic Subcategory

Pricing Policy & Schemes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×